Picture of Scandinavian ChemoTech AB logo

CMOTEC B Scandinavian ChemoTech AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Scandinavian ChemoTech AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-17.1-20.9-20.2-12.8
Depreciation
Non-Cash Items0.0550.409-0.249-0.802
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.98-1.93-0.42-1.61-3.74
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-19.2-19.5-18.2-13.1-3.74
Capital Expenditures-3.18-0.331-0.68-0.046
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.15-0.2720.2120.044-0.426
Other Investing Cash Flow
Cash from Investing Activities-3.33-0.603-0.468-0.002-0.426
Financing Cash Flow Items6.89
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities29.717.313.813.26.89
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7.2-2.83-4.930.0262.72